ATOSSA THERAPEUTICS INC. - COMMON STOCK

0.9603

06-January-25 15:45:00

15 minutes delayed

Stocks

-0.0497

-4.92%

Today's range

0.9600 - 1.0250

ISIN

N/A

Source

NASDAQ

Atossa Therapeutics and Quantum Leap Healthcare Provide Enrollment Update for (Z)-Endoxifen Arm of Ongoing I-SPY 2 Clinical Trial

28 Jun 2023 08:15:00 By Nasdaq GlobeNewswire
Atossa Therapeutics Announces $10M Stock Repurchase Program

27 Jun 2023 08:15:00 By Nasdaq GlobeNewswire
Atossa Therapeutics Announces Sponsorship of Are You Dense MusicFest 2023

22 Jun 2023 15:15:00 By Nasdaq GlobeNewswire
Atossa Therapeutics Granted Additional Patent Protection for Endoxifen

21 Jun 2023 09:13:54 By Nasdaq GlobeNewswire
Atossa to Participate in Fireside Chat at Healthcare Virtual Conference Presented by Maxim Group LLC

14 Jun 2023 08:15:00 By Nasdaq GlobeNewswire
Atossa Completes Enrollment of Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer

12 Jun 2023 08:15:00 By Nasdaq GlobeNewswire
Atossa Appoints Life Sciences Financial and Operations Industry Veteran Greg Weaver as Chief Financial Officer

01 Jun 2023 08:10:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.